References

Report and enquiry into the impact of skin diseases on people's lives.London: APPGS; 2003

Ashton R, Leppard B, Cooper H. Differential diagnosis in dermatology, 4th edn. London: CRC Press; 2005

Buchanan P, Courtenay M. Topical treatments for managing patients with eczema. Nurs Stand. 2007; 21:(41)45-50 https://doi.org/10.7748/ns2007.06.21.41.45.c4632

Ersser S, Maguire S, Nicol N, Penzer R, Peters J. Best practice in emollient therapy: a statement for healthcare professionals.Aberdeen: Dermatology UK; 2007

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19:(3)210-216

Lawton S. Assessing and treating adult patients with eczema. Prim Health Care. 2010; 20:(4)32-38 https://doi.org/10.7748/phc2010.05.20.4.32.c7770

Long C, Finlay AY. The finger-tip-unit—a new practical measure. Clin Exp Dermatol. 1991; 16:444-447

Using topical corticosteroids in general practice. MeReC Bull. 1999; 10:(6)21-24

Medicines and Healthcare Products Regulatory Agency. Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients. 2019. https://tinyurl.com/y6cps8wz (accessed 5 February 2019)

National Eczema Society. Living with eczema—information for adults with eczema. 2010. http://www.eczema.org/products/102 (accessed 5 February 2019)

National Institute for Health and Care Excellence. Corticosteroids—topical (skin), nose, and eyes. 2018. https://tinyurl.com/y6lb4daw (accessed 31 January 2019)

Royal Pharmaceutical Society. Medicines complete. 2019. https://tinyurl.com/y3a68nfw (accessed 5 February 2019)

van Onselen J. Eczema: a common skin condition for older people. Nursing and Residential Care. 2013; 15:(1)14-20 https://doi.org/10.12968/nrec.2013.15.1.14

Walling HW, Swick BL. Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol. 2010; 3:99-117

Assessment and management of eczema in adults in the community setting

02 March 2019
Volume 24 · Issue 3

Eczema describes a set of inflammatory skin disorders characterised by dry, red, itchy skin. It presents on different body sites depending on the cause and is one of the most common skin conditions, affecting 1 in every 12 adults (All Party Parliamentary Group on Skin, 2003; National Eczema Society, 2010). Eczema is a highly individual and variable condition, often presenting in the long term, although it can exhibit acute episodes as well. Since it is a challenge to self manage, nurses, particularly those working in the community setting, must be confident in knowing how to support patients. This may be by accessing appropriate information, providing choices of emollient products to use, optimising topical therapies, providing medical advice and signposting patients when needed.

This article outlines the different presentations of eczema in adulthood and how to recognise and treat them. For community prescribers, it is important that they are knowledgeable about local formularies and the first-line therapies available, as well as when it is appropriate to suggest over-the-counter products.

Definition of eczema

Eczema can be classified as endogenous, exogenous or having no known cause (Ashton et al, 2005). Endogenous eczema develops as a result of internal factors that compromise the skin's integrity, for example, atopy (a predisposition to allergic conditions such as asthma, hayfever and eczema), or venous hypertension/varicose veins leading to eczema on the lower legs.

Exogenous eczema develops as a result of contact with external agents in the person's environment that irritate the skin, such as chemicals, fragrances, metals and dyes. Unclassified eczema presents when there is no clear endogenous or exogenous cause.

Regardless of the cause, the symptoms of eczema are the same, although they could be widespread or localised depending on the cause (Figures 16).

Figure 1. Discoid eczema
Figure 2. Varicose eczema
Figure 3. Asteatotic eczema
Figure 4. Contact dermatitis
Figure 5. Pompholyx
Figure 6. Seborrhoeic eczema

Diagnostic features and types of eczema

Although eczema presents several characteristics that are useful for diagnosis, some of these are non-specific, so the features must be assessed holistically for accurate diagnosis. The main diagnostic features of eczema include pruritus or itching; eczematous eruption with inflammation, redness and possibly vesicles (small blisters); dryness and scaling; a tendency towards ‘sensitive’ skin; a personal history of asthma or allergic rhinitis and childhood onset of eczema (Walling and Swick, 2010).

Adults can experience various forms of eczema:

  • Asteototic eczema—‘crazy paving appearance’ that is exacerbated by low humidity and central heating
  • Eczematous drug eruptions—these underscore the need for thorough taking of drug history
  • Varicose—also known as gravitational, stasis or venous eczema on the lower leg due to venous hypertension
  • Lichen simplex—also known as neurodermatitis, resulting from stress or the habit of repeated scratching, which causes thick skin
  • Atopic—reoccurrence of childhood eczema, maybe with asthma and hayfever
  • Contact dermatitis—irritant or allergic response where the skin is repeatedly exposed to external allergens, e.g. fragrance, nickel and hair dyes
  • Discoid/nummular—well-demarcated, round or disc-shaped patches, often on the trunk and limbs
  • Seborrhoeic—in response to a yeast infection on the skin, usually on the face, nasolabial folds, eyebrows, groin, armpits or skin folds, with greasy-looking scale
  • Photosensitive—occurs in response to sunlight with or without aggravation from chemicals in contact with sunlight, e.g. fragrances
  • Pompholyx—blistering eczema on the hands and feet, which can be triggered by a contact dermatitis response to allergens.
  • Assessment

    A holistic assessment to determine the cause of eczema should include the following:

  • Age and general history—how long the eczema has been present and where it started
  • Past medical history, illnesses, operations, previous skin disease, history of allergic illnesses
  • Current medication, prescription and over-the-counter, including herbal remedies, vitamins, etc.
  • Family history of skin disease
  • Social history, including present or previous occupation, hobbies and list of objects, materials and substances that are in contact with the skin regularly, e.g. gardening, pottery and car maintenance
  • What improves it or makes it worse?, e.g. changes in temperature, physical or emotional stress, pets, smoking, alcohol, make up, perfume, clothing, jewellery and gloves
  • What treatments have been tried, prescription or over-the-counter? Have they helped?
  • Physical examination to check distribution, character and shape of lesions:
  • Hands or feet, body, light-exposed skin, flexures, lower legs, face or scalp
  • Are the areas small or large, round, ring-shaped or linear?
  • Redness, scaling, crusting, blisters, pustules, erosions, nodules (hard lumps) (Lawton, 2010)
  • Psychological assessment—psychological morbidity, feelings of isolation, anxiety and depression are frequently reported by patients with severe eczema. The effect that eczema has on a patient in terms of their quality of life, ability to perform activities of daily living, employability and personal relationships should be considered as part of the overall assessment. There are a variety of validated assessment tools that can be used for this, such as the Dermatology Life Quality Index (Finlay and Khan, 1994; Buchanan and Courtenay, 2007), among others.
  • Treatment for eczema

    The aim of treating any form of eczema is three pronged: to repair and maintain good skin integrity, alleviate symptoms and improve quality of life. Older people may need more time and explanations in order to understand the condition and the therapies suggested. Within a community setting, the mainstay of treatments for eczema are topical. Table 1 provides a review of treatments that can be used within primary and community care settings.


    Lifestyle interventions Avoidance of soap-based products, i.e. shower gel, bubble bath, soap, shampoo, Dettol
    Bathing technique—discuss use of soap substitutes or bath mats
    Humidification of environment, not too hot or dry
    Avoidance of exacerbants or irritants if known, e.g. soaps and fragrances
    Wash hair separately from body to avoid shampoo suds on the skin
    Avoid animal dander or damp dust when cleaning to avoid releasing dust
    Topical therapy Emollients or moisturisers to be used as soap substitutes as well as leave-on applications to soak into the skin to rehydrate or provide occlusion. See local formulary or Medicines Complete (Royal Pharmaceutical Society, 2019) for products. These include creams, gels, sprays and ointments
    Application of all topical treatments in line with hair growth to avoid folliculitis, i.e. downward strokes
    Antibacterial emollient washes for those with broken skin at risk of infection
    Appropriate leave-on emollient—level of greasiness depends on how dry the skin is, e.g. cream or gel/ointment
    Discuss fire hazard with the use of paraffin- and non-paraffin-based emollients (Ersser et al, 2007; Medicines and Healthcare Products Regulatory Agency, 2019)
    Topical corticosteroids (first line)—when eczema is inflamed, red, irritated and itchy. Four strengths of steroids—mild, moderate, potent and very potent
    Potency depends on body site and severity of eczema, e.g. facial or genital eczema requires mild/moderate potency, whereas the palms or soles may need very potent. Discuss this with the prescriber
    Finger tip units (FTU) are a guide to the amount to use, e.g. one finger tip full of steroid, from the finger tip to first crease of finger/1/3 finger, is enough to cover the amount of eczema measured by two flat palms. An adult may need up to 7 FTUs to cover their trunk if extensive (Long and Finlay, 1991)
    Aim for period to settle eczema and then step down frequency, e.g. daily for 7 days, then 3x a week, 2x week then stop (MeReC, 1999; NICE 2018)
    Anti-yeast ingredients needed in combination with steroid for seborrhoeic eczema
    Management of venous hypertension with compression in addition to topical therapies for varicose eczema
    Topical calcineurin inhibitors (second-line therapy when steroids are ineffective, with advise from dermatology specialist practitioner), e.g. tacrolimus and pimecrolimus
    Source: adapted from van Onselen, 2013

    Referral to secondary care

    Not all red and itchy skin is eczema. If more than one person within a residential setting has symptoms, then it is important to consider scabies. Other itchy skin conditions include urticaria, blistering or bullous disorders (pre-blistering) and fungal infections. Some systemic conditions also present with itchy skin, but without a rash, such as diabetes, renal or liver failure, hyperthyroidism, anaemia and leukaemia. If in doubt, a dermatological opinion should be sought, which will usually be in a secondary care setting.

    Conclusion

    Eczema is a common skin condition in adults and may impair quality of life and lead to breakdown of skin integrity if not identified and managed. Community nurses are well placed to examine patients' skin and recognise dry skin, a precursor to an eczematous response, as well as identify eczema itself. Referring to local formularies will enable staff to appropriately manage eczema with emollients and topical steroids. Staff can supplement their knowledge by referring to material from the National Eczema Society (2010) as well as other reputable dermatology sources.